A Randomized, placebo-controlled pilot trial to investigate the safety and efficacy of MLC901 (NEUROAID IITM) in adults following mild or moderate traumatic brain injury

被引:0
|
作者
Theadom, A. [1 ]
Bhattacharjee, R. [1 ]
Parmar, P. [1 ]
Feigin, V. [1 ]
机构
[1] Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand
关键词
D O I
10.1016/j.jns.2017.08.346
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
320
引用
收藏
页码:109 / 109
页数:1
相关论文
共 50 条
  • [21] A Double-Blind, Placebo-Controlled, Randomized Phase II Pilot Study to Investigate the Potential Efficacy of the Traditional Chinese Medicine Neuroaid (MLC 601) in Enhancing Recovery after Stroke (TIERS)
    Kong, Keng He
    Wee, Seng Kwee
    Ng, Chwee Yin
    Chua, Karen
    Chan, Kay Fei
    Venketasubramanian, N.
    Chen, Christopher
    CEREBROVASCULAR DISEASES, 2009, 28 (05) : 514 - 521
  • [22] Effects of methylphenidate on attentional function after traumatic brain injury - A randomized, placebo-controlled trial
    Whyte, J
    Hart, T
    Schuster, K
    Fleming, M
    Polansky, M
    Coslett, HB
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 1997, 76 (06) : 440 - 450
  • [23] A randomized controlled trial on the efficacy, safety, and pharmacokinetics of metformin in severe traumatic brain injury
    Taheri, Ali
    Emami, Mahdi
    Asadipour, Erfan
    Kasirzadeh, Sara
    Rouini, Mohammad-Reza
    Najafi, Atabak
    Heshmat, Ramin
    Abdollahi, Mohammad
    Mojtahedzadeh, Mojtaba
    JOURNAL OF NEUROLOGY, 2019, 266 (08) : 1988 - 1997
  • [24] A randomized controlled trial on the efficacy, safety, and pharmacokinetics of metformin in severe traumatic brain injury
    Ali Taheri
    Mahdi Emami
    Erfan Asadipour
    Sara Kasirzadeh
    Mohammad-Reza Rouini
    Atabak Najafi
    Ramin Heshmat
    Mohammad Abdollahi
    Mojtaba Mojtahedzadeh
    Journal of Neurology, 2019, 266 : 1988 - 1997
  • [25] Efficacy of Intervention of Participation and Executive Functions (I-PEX) for Adults Following Traumatic Brain Injury: A Preliminary Pilot Randomized Controlled Trial
    Eliav, Rotem
    Nadler Tzadok, Yael
    Segal-Rotenberg, Shir
    Kizony, Rachel
    NEUROREHABILITATION AND NEURAL REPAIR, 2024, 38 (04) : 279 - 290
  • [26] Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
    Anan Manomaipiboon
    Kittisak Pholtawornkulchai
    Sujaree Poopipatpab
    Swangjit Suraamornkul
    Jakravoot Maneerit
    Wiroj Ruksakul
    Uraporn Phumisantiphong
    Thananda Trakarnvanich
    Trials, 23
  • [27] Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis
    Chmiel, James F.
    Flume, Patrick
    Downey, Damian G.
    Dozor, Allen J.
    Colombo, Carla
    Mazurek, Henryk
    Sapiejka, Ewa
    Rachel, Marta
    Constantine, Scott
    Conley, Brian
    Dgetluck, Nancy
    Dinh, Quinn
    White, Barbara
    Elborn, J. Stuart
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (01) : 78 - 85
  • [28] Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
    Manomaipiboon, Anan
    Pholtawornkulchai, Kittisak
    Poopipatpab, Sujaree
    Suraamornkul, Swangjit
    Maneerit, Jakravoot
    Ruksakul, Wiroj
    Phumisantiphong, Uraporn
    Trakarnvanich, Thananda
    TRIALS, 2022, 23 (01)
  • [29] Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis
    Spiera, Robert
    Hummers, Laura
    Chung, Lorinda
    Frech, Tracy M.
    Domsic, Robyn
    Hsu, Vivien
    Furst, Daniel E.
    Gordon, Jessica
    Mayes, Maureen
    Simms, Robert
    Lafyatis, Robert
    Martyanov, Viktor
    Wood, Tammara
    Whitfield, Michael L.
    Constantine, Scott
    Lee, Elizabeth
    Dgetluck, Nancy
    White, Barbara
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (08) : 1350 - 1360
  • [30] A Double-Blind Placebo-Controlled, Randomized Trial of Divalproex Sodium for Posttraumatic Irritability Greater Than 1 Year After Mild to Moderate Traumatic Brain Injury
    Beresford, Thomas
    Ronan, Patrick J.
    Hipp, Daniel
    Schmidt, Brandon
    Thumm, E. Brie
    Temple, Benjamin
    Wortzel, Hal
    Weitzenkamp, David
    Emrick, Chad
    Kelly, James
    Arciniegas, David B.
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2022, 34 (03) : 224 - 232